Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CCCC | C4 Therapeutics, Inc. | Chief Financial Officer | $318K | Aug 30, 2023 | ||
IMGN | ImmunoGen, Inc. | Svp, Cfo And Pfo | $0 | Feb 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|